Arbutus Biopharma Corp

Small-Cap Stocks Penny Stocks Biotech Stocks Healthcare Stocks

$4.34

-0.07 (-1.59%)

As of Aug 8, 1:48 AM ET ·

Analyst Consensus

Strong Buy

Analysts

Moderate

Coverage

Buy 8 89%

Hold 1 11%

Sell 0 0%

Price Target

Analyst Price Target +1,080.9% upside

Low Target $34.47

Average Target $51.25

High Target $59.24

Current Price $4.34

Current
$4.34

Target
$51.25

$34.47 $51.25 avg $59.24

Scenario Analysis

Bear Case

$34.47

694.2%

Low target

Base Case

$51.25

+1,080.9%

Avg target

Bull Case

$59.24

+1,265.0%

High target

Risk/Reward

1.8x

Balanced

Price in Context

52-Week High

$5.38

-19.3% from high

52-Week Low

$3.31

+31.1% from low

Target vs 52W High

$51.25

+852.6% vs high

Peer Consensus — Biotechnology

Stock	Consensus	Analysts	Buy %	Target	Upside
ABBV Abbvie Inc	Strong Buy	39	79%	$257.58	+4.7%
AMGN Amgen Inc	Hold	43	49%	$190.87	-53.6%
GILD Gilead Sciences Inc	Strong Buy	37	81%	$362.68	+172.3%
VRTX Vertex Pharmaceuticals Inc	Strong Buy	40	83%	$438.34	-11.6%
REGN Regeneron Pharmaceuticals	Buy	38	71%	$76.80	-90.2%
NTRA Natera Inc	Strong Buy	30	87%	$142.91	-55.6%
RVMD Revolution Medicines Inc	Strong Buy	29	93%	$114.11	-44.4%
BIIB Biogen Inc	Buy	44	64%	$91.45	-56.0%